semaglutide injection baton rouge Unique Physique (@uniquephysiquebr) · Rouge, LA Weight Loss | Highland Hills

50.5% lost 15% or more

30.3% at 104 weeks in a BMI 35 extension cohort TRANSCEND-T2D-1 confirmed (topline March 2026, published June 2026): First completed diabetes-specific Phase 3 trial -2.0% HbA1c and 16.8% weight loss in 537 patients, a separate program from TRIUMPH NDA timeline unchanged: industry estimates continue to expect Q4 2026 filing, based on standard practice following TRIUMPH-1's primary readout OSA data confirmed (ADA June 6, 2026): TRIUMPH-1's nested sleep apnea substudy showed 60.6% AHI reduction from a severe-OSA baseline of 58.6 events/hour This page updates after every trial announcement bookmark for the latest Introduction Retatrutide stands at the forefront of obesity medicine a first-in-class triple hormone agonist that has demonstrated some of the highest weight loss efficacy ever recorded in clinical trials

Secreted ATP feeds back to type II cells in order to push further signaling or to stimulate type III cells [37]

10.1021/acsami.9b10346